- Home
- MET vs BDX Comparison
MET vs BDX Comparison
Compare MET & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MET | BDX |
|---|---|---|
| Founded | 1863 | 1897 |
| Country | United States | United States |
| Employees | 46000 | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3B | 51.5B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | MET | BDX |
|---|---|---|
| Price | $84.49 | $151.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $93.93 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 2.9M | 2.8M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 2.88% | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $4.40 | N/A |
| Revenue Next Year | $4.51 | $3.02 |
| P/E Ratio | ★ $16.82 | $597.96 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $67.33 | $141.82 |
| 52 Week High | $85.29 | $213.08 |
Technical Indicators
Market Signals| Indicator | MET | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 62.90 | 57.02 |
| Support Level | $77.59 | $141.82 |
| Resistance Level | $85.29 | $159.79 |
| Average True Range (ATR) | 1.80 | 3.59 |
| MACD | -0.08 | 0.86 |
| Stochastic Oscillator | 83.83 | 87.57 |
Price Performance
Historical ComparisonAbout MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
About BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.